Target intelligence / Profile preview

Antioxidant protein 1 copper chaperone (ATOX1)

Target
ATOX1
Molecular classification
Copper chaperone, Metallochaperone, Transporter, Other (Redox regulator, Transcription factor—Cu-dependent, less established)
01

Overview

Antioxidant protein 1 copper chaperone (ATOX1) is a small, highly conserved cytosolic protein that regulates intracellular copper distribution by delivering copper ions from the cytosol to ATPase transporters ATP7A and ATP7B in the secretory pathway. It ensures maturation and activity of several copper-dependent enzymes essential for neurotransmitter biosynthesis, iron metabolism (ceruloplasmin), neovascularization, wound healing, and blood pressure regulation. ATOX1 provides antioxidant protection both by direct sequestration of copper (limiting reactive oxygen species) and enhancing copper-dependent antioxidant enzymes. Beyond its chaperone function, ATOX1 has emerging roles as a transcription factor and regulator of inflammatory/angiogenic responses, particularly in cancer and cardiovascular disease contexts. The protein features a classic ferredoxin-like fold and a conserved MxCxxC motif that tightly coordinates copper(I), and may form adducts with drugs such as cisplatin. Loss or dysfunction of ATOX1 disrupts copper and redox homeostasis and can sensitize cells to oxidative damage or impair cellular proliferation and differentiation.

Other names
Copper transport protein ATOX1HAH1Metal transport protein ATX1ATX1 antioxidant protein 1 homologmetal transport protein ATX1
02

Mechanism of action

Drugs like cisplatin may bind to ATOX1's cysteine-rich copper-binding motif, potentially interfering with copper transport. Copper chelators alter the copper transfer process, impacting ATOX1-dependent copper homeostasis. LOX inhibitors reduce downstream angiogenesis that depends on ATOX1-facilitated copper delivery.

03

Biological functions

Copper transport and homeostasisActivation of copper-dependent enzymesAntioxidant defenseRegulation of redox balanceAngiogenesis (through copper-dependent extracellular matrix modification)Iron efflux (indirect, via activation of ceruloplasmin)Regulation of blood pressure, wound healing (via copper enzyme maturation)Cell differentiation, proliferation (as a transcriptional regulator)
04

Disease associations

Cancer (implicated in carcinogenesis and therapy resistance)InflammationCardiovascular disease (e.g., angiogenesis in ischemic tissues)Neurodegenerative disease (by copper/redox imbalance)Other (potential—wound healing disorders, metabolic conditions)
05

Safety considerations

Disruption of copper homeostasis may lead to cellular toxicity, oxidative stress, or impaired enzyme maturationModulating ATOX1 function could cause neurotoxicity or worsen metabolic imbalances if not selective
06

Interacting drugs

Cisplatin (forms adducts with ATOX1's copper-binding motif)

2 more in the full profile.

07

Biomarkers

ATOX1 expression levels (potential biomarker for cancer therapy responsiveness, inflammatory angiogenesis)

Beyond the preview

Go deeper on Antioxidant protein 1 copper chaperone (ATOX1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antioxidant protein 1 copper chaperone (ATOX1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call